Company / Return on Assets (ROA)
Twist Bioscience Corp Return on Assets (ROA) History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Assets (ROA)
-12.1%
FY2025
5-year range
-34.0% / -12.1%
FY2021-FY2025
Trend
+64.4%
vs FY2024
Sector context
#90 of 213
Health Care
What the data says
At -12.1%, Twist Bioscience Corp's return on assets (roa) ranks #90 of 213 in the Health Care sector. Return on Assets (ROA) returned to growth in FY2025 after 3 years of decline, reaching -12.1%.
Based on SEC 10-K filings.
-12.1% in FY2025 with a 5-year CAGR of +23.0%.
Improved from -26.4% to -12.1% over the past 2 years.
Health Care sector context is included.
Return on Assets (ROA) over time
Growth rates
- 3-Year Change
- +10.6pp
- 5-Year Change
- +23.0pp
- 10-Year Change
- -
Sector benchmark
#90 of 213 in Health CareTop 42% of 213This company -12.1% Sector average -24.1%
▼
+49.7% above sector average
Key checks
Key Insights
- In FY2025, return on assets (roa) increased 64.4% year-over-year.
- Currently 12.0pp above the Health Care sector average.
- Lowest return on assets (roa) in the period was in FY2018.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 0.79 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Return on Assets (ROA)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -12.1% | +64.4% |
| FY2024 | -34.0% | -29.0% |
| FY2023 | -26.4% | -16.3% |
| FY2022 | -22.7% | -4.6% |
| FY2021 | -21.7% | +38.3% |
| FY2020 | -35.1% | +39.1% |
| FY2019 | -57.6% | +6.4% |
| FY2018 | -61.5% | - |
| FY2017 | - | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026